FDA taking first steps toward regulation of CBD products


The Food and Drug Administration is set to take its first step Friday toward regulating cannabidiol, or CBD.

The CBD product craze — with its myriad oils, capsules, gummies, lotions and potions — has exploded into a frenzy never before seen in the supplement industry.

On Friday, the FDA will hold its first public hearing on cannabis and cannabis-derived compounds, the most popular of which is CBD.

Ga naar Bron